BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 26733406)

  • 1. Healthcare Utilisation and Drug Treatment in a Large Cohort of Patients with Inflammatory Bowel Disease.
    Cars T; Wettermark B; Löfberg R; Eriksson I; Sundström J; Lördal M
    J Crohns Colitis; 2016 May; 10(5):556-65. PubMed ID: 26733406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil.
    Parra RS; Chebli JMF; Amarante HMBS; Flores C; Parente JML; Ramos O; Fernandes M; Rocha JJR; Feitosa MR; Feres O; Scotton AS; Nones RB; Lima MM; Zaltman C; Goncalves CD; Guimaraes IM; Santana GO; Sassaki LY; Hossne RS; Bafutto M; Junior RLK; Faria MAG; Miszputen SJ; Gomes TNF; Catapani WR; Faria AA; Souza SCS; Caratin RF; Senra JT; Ferrari MLA
    World J Gastroenterol; 2019 Oct; 25(38):5862-5882. PubMed ID: 31636478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden.
    Everhov ÅH; Halfvarson J; Myrelid P; Sachs MC; Nordenvall C; Söderling J; Ekbom A; Neovius M; Ludvigsson JF; Askling J; Olén O
    Gastroenterology; 2018 Feb; 154(3):518-528.e15. PubMed ID: 29102619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory bowel disease: A descriptive study of 716 local Chilean patients.
    Simian D; Fluxá D; Flores L; Lubascher J; Ibáñez P; Figueroa C; Kronberg U; Acuña R; Moreno M; Quera R
    World J Gastroenterol; 2016 Jun; 22(22):5267-75. PubMed ID: 27298570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introduction of anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases: a population-based interrupted time series study.
    Murthy SK; Begum J; Benchimol EI; Bernstein CN; Kaplan GG; McCurdy JD; Singh H; Targownik L; Taljaard M
    Gut; 2020 Feb; 69(2):274-282. PubMed ID: 31196874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and Long-term Outcome of Inflammatory Bowel Disease Diagnosed at Elderly Age-An Increasing Distinct Entity?
    Jeuring SF; van den Heuvel TR; Zeegers MP; Hameeteman WH; Romberg-Camps MJ; Oostenbrug LE; Masclee AA; Jonkers DM; Pierik MJ
    Inflamm Bowel Dis; 2016 Jun; 22(6):1425-34. PubMed ID: 26933752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower regional and temporal ultraviolet exposure is associated with increased rates and severity of inflammatory bowel disease hospitalisation.
    Limketkai BN; Bayless TM; Brant SR; Hutfless SM
    Aliment Pharmacol Ther; 2014 Sep; 40(5):508-17. PubMed ID: 24943863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of paediatric inflammatory bowel disease in Sweden: a nationwide population-based register study.
    Ludvigsson JF; Büsch K; Olén O; Askling J; Smedby KE; Ekbom A; Lindberg E; Neovius M
    BMC Gastroenterol; 2017 Jan; 17(1):23. PubMed ID: 28143594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study.
    van der Valk ME; Mangen MJ; Leenders M; Dijkstra G; van Bodegraven AA; Fidder HH; de Jong DJ; Pierik M; van der Woude CJ; Romberg-Camps MJ; Clemens CH; Jansen JM; Mahmmod N; van de Meeberg PC; van der Meulen-de Jong AE; Ponsioen CY; Bolwerk CJ; Vermeijden JR; Siersema PD; van Oijen MG; Oldenburg B;
    Gut; 2014 Jan; 63(1):72-9. PubMed ID: 23135759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic management of inflammatory bowel disease in real-life practice in the current era of anti-TNF agents: analysis of the French administrative health databases 2009-2014.
    Kirchgesner J; Lemaitre M; Rudnichi A; Racine A; Zureik M; Carbonnel F; Dray-Spira R
    Aliment Pharmacol Ther; 2017 Jan; 45(1):37-49. PubMed ID: 27781286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-World Treatment Patterns and Healthcare Resource Use for Ulcerative Colitis and Crohn's Disease in Italy.
    Dovizio M; Hartz S; Buzzoni C; Redondo I; Nedeljkovic Protic M; Birra D; Perrone V; Veronesi C; Degli Esposti L; Armuzzi A
    Adv Ther; 2024 Jun; 41(6):2282-2298. PubMed ID: 38619721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm County.
    Ljung T; Karlén P; Schmidt D; Hellström PM; Lapidus A; Janczewska I; Sjöqvist U; Löfberg R
    Gut; 2004 Jun; 53(6):849-53. PubMed ID: 15138212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical status, psychosocial impairments, medical treatment and health care costs for patients with inflammatory bowel disease (IBD) in Germany: an online IBD registry.
    Bokemeyer B; Hardt J; Hüppe D; Prenzler A; Conrad S; Düffelmeyer M; Hartmann P; Hoffstadt M; Klugmann T; Schmidt C; Weismüller J; Mittendorf T; Raspe H
    J Crohns Colitis; 2013 Jun; 7(5):355-68. PubMed ID: 22503168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in hospitalization rates for inflammatory bowel disease in the United States.
    Bewtra M; Su C; Lewis JD
    Clin Gastroenterol Hepatol; 2007 May; 5(5):597-601. PubMed ID: 17382602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergency department utilisation for inflammatory bowel disease in the United States from 2006 to 2014.
    Ballou S; Hirsch W; Singh P; Rangan V; Nee J; Iturrino J; Sommers T; Zubiago J; Sengupta N; Bollom A; Jones M; Moss AC; Flier SN; Cheifetz AS; Lembo A
    Aliment Pharmacol Ther; 2018 Apr; 47(7):913-921. PubMed ID: 29411411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and Clinical Outcomes of Inflammatory Bowel Disease in South Korea, 2011-2014: A Nationwide Population-Based Study.
    Jung YS; Han M; Kim WH; Park S; Cheon JH
    Dig Dis Sci; 2017 Aug; 62(8):2102-2112. PubMed ID: 28593437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in inflammatory bowel disease subtype during follow-up and over time in 44,302 patients.
    Everhov ÅH; Sachs MC; Malmborg P; Nordenvall C; Myrelid P; Khalili H; Elmberg M; Ekbom A; Askling J; Jakobsson G; Halfvarson J; Ludvigsson JF; Olén O
    Scand J Gastroenterol; 2019 Jan; 54(1):55-63. PubMed ID: 30700170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between prior healthcare use, time to diagnosis, and clinical outcomes in inflammatory bowel disease: a nationally representative population-based cohort study.
    Jayasooriya N; Saxena S; Blackwell J; Bottle A; Creese H; Petersen I; Pollok RCG;
    BMJ Open Gastroenterol; 2024 May; 11(1):. PubMed ID: 38802264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low prevalence of anemia in inflammatory bowel disease: a population-based study in Sweden.
    Rejler M; Tholstrup J; Andersson-Gäre B; Spångéus A
    Scand J Gastroenterol; 2012 Sep; 47(8-9):937-42. PubMed ID: 22571405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.